Researchers led by a team at Baylor College of Medicine have identified a novel neurodevelopmental disorder associated with mutations or deletions affecting a gene called PAX5. Their findings are published in the journal ...
Jan 31, 2022
0
31
Researchers led by Michiko Mandai at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have used a genetic modification to improve human-derived retina transplants grown in the lab. After transplant into damaged ...
Jan 27, 2022
0
6
A new risk score can identify men and women under age 50 most likely to develop a cancer of the colon or rectum, an international study shows.
Jan 27, 2022
0
2
There is no evidence of recently infected mothers transmitting infectious SARS-CoV-2 through breastmilk to their baby, reports a study published in the journal Pediatric Research. The authors found that, whilst a low proportion ...
Jan 19, 2022
0
7
Hormone levels in the womb before birth have been potentially linked to the risk of developing migraine in adulthood, reveals a new study of genetic and environmental information from the world's largest database of twins. ...
Dec 16, 2021
0
35
Certain kinds of tumors can be inherited within families. Identifying the underlying genetic cause is important in treatment, but most studies on these tumors have been carried out on Caucasian populations. Now, a research ...
Nov 19, 2021
0
33
A recent study published in Circulation: Genomic and Precision Medicine found that using genetic information to prescribe medications following a stent's being placed after a heart attack reduces the risk of fatal outcomes ...
Nov 4, 2021
0
1
In the United States, Black women are more likely to have breast cancer at earlier ages and with a worse prognosis than white women. Despite this, there is a critical gap in breast cancer risk prediction models for Black ...
Oct 29, 2021
0
2
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, ...
Oct 6, 2021
0
2
US pharmaceutical company Merck said Friday it will seek authorization of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent.
Oct 1, 2021
0
37
